References
- Tonti GA, Mannello F. From bone marrow to therapeutic applications: Different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol. 2008;52(8):1023–1032.
- Wong R. Mesenchymal stem cells: Angels or demons?. J Biomed Biotechnol. 2011;2011:1–8.
- de Araújo Farias V, Carrillo-Gálvez AB, Martín F, et al. TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer. Cytokine Growth Factor Rev. 2018;43(June):25–37.
- Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013;2013:1–8.
- Avnet S, Lemma S, Cortini M, et al. Pre-clinical models for studying the interaction between mesenchymal stromal cells and cancer cells and the induction of stemness. Front Oncol. 2019;9(APR):1–8.
- Adamo A, Dal Collo G, Bazzoni R, et al. Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment. Biochim Biophys Acta - Rev Cancer. 2019;1871(1):192–198.
- Laplagne C, Domagala M, Le Naour A, et al. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression. IJMS. 2019;20(19):4719.
- Rhee KJ, Lee JI, Eom YW. Mesenchymal stem cell-mediated effects of tumor support or suppression. IJMS. 2015;16(12):30015–30033.
- Barcellos-de-Souza P, Gori V, Bambi F, et al. Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta - Rev Cancer. 2013;1836(2):321–335.
- Nakamizo A, Marini F, Amano T, et al. Human Bone Marrow – Derived Mesenchymal Stem Cells in the Treatment of Gliomas. Cancer Res. 2005;65(8):3307–3318.
- Khakoo AY, Pati S, Anderson S. a, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 2006;203(5):1235–1247.
- Klopp AH, Gupta A, Spaeth E, et al. Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth?. Stem Cells. 2011;29(1):11–19.
- Tai S, Sun Y, Squires JM, et al. PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate. 2011;71(15):1668–1679.
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- Bochev I, Elmadjian G, Kyurkchiev D, et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int. 2008;32(4):384–393.
- Han I, Yun M, Kim E-O, et al. Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. Stem Cell Res Ther. 2014;5(2):54.
- Takahara K, Ii M, Inamoto T, et al. Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis. Biochem Biophys Res Commun. 2014;446(4):1102–1107.
- Cavarretta IT, Altanerova V, Matuskova M, et al. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther. 2010;18(1):223–231.
- Zhu Y, Sun Z, Han Q, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leuk off J Leuk Soc Am Leuk Res Fund, UK. 2009;23(5):925–933.
- Ramasamy R, Lam E-F, Soeiro I, et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 2007;21(2):304–310.
- Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21(3):485–495.
- Yang C, Lei D, Ouyang W, et al. Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro. Biomed Res Int. 2014;2014:1–13.
- Du J, Zhou L, Chen X, et al. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. Int J Biochem Cell Biol. 2012;44(8):1305–1314.
- Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol. 2013;23(12):620–633.
- Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 2005;5(3):231–237.
- Rahman M, Davis SR, Pumphrey JG, et al. TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat. 2009;113(2):217–230.